Paul A Clark

10PUBLICATIONS
63CO-AUTHORS
Radiation therapyEpigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 23, 2026
Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors.

|Jan 26, 2026
Priming versus propagating: distinct immune effects of alpha- versus beta-particle emitting radiopharmaceuticals when combined with immune checkpoint inhibition in mice.

Caroline P Kerr, Won Jong Jin, Peng Liu

|Jul 25, 2025
SUZ12-Nucleic Acid Interactions Constrain PRC2 Activity to Maintain Targeted Gene Silencing Essential to Diffuse Midline Glioma.

Tyler J Reich, Paul A Clark, Audrey Baguette

|May 29, 2025
The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor Efficacy.

Caroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski

|Sep 18, 2024
Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade.

Justin C Jagodinsky, Jessica M Vera, Won Jong Jin

|Oct 03, 2022
Local TLR4 stimulation augments in situ vaccination induced via local radiation and anti-CTLA-4 checkpoint blockade through induction of CD8 T-cell independent Th1 polarization.

Justin C Jagodinsky, Amber M Bates, Paul A Clark

Pageof 2

Frequent Collaborators

5 joint publications

Zachary S Morris

4 joint publications

Justin C Jagodinsky

3 joint publications

Amanda G Shea

3 joint publications

Ohyun Kwon